CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS’ EQUITY - USD ($) shares in Millions, $ in Millions	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Jul. 01, 2022	0
Beginning balance at Jul. 01, 2022	$ 0
Ending balance (in shares) at Sep. 30, 2022	0
Ending balance at Sep. 30, 2022	$ 0
Common stock, beginning balance (in shares) at Jul. 01, 2022			315
Beginning balance at Jul. 01, 2022	12,323	$ (37)	$ 3	$ 3,733	$ (128)	$ (579)	$ 9,166	$ 91
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net(loss) income	47						47
Employee stock plans (in shares)			3
Employee stock plans	(50)			(50)
Stock-based compensation	86			86
Foreign currency translation adjustment	(87)					(87)
Net unrealized gain (loss) on derivative contracts	(60)					(60)
Common stock, ending balance (in shares) at Sep. 30, 2022			318
Ending balance at Sep. 30, 2022	$ 12,222		$ 3	3,641		(726)	9,304
Beginning balance (in shares) at Jul. 01, 2022	0
Beginning balance at Jul. 01, 2022	$ 0
Ending balance (in shares) at Mar. 31, 2023	1
Ending balance at Mar. 31, 2023	$ 876
Common stock, beginning balance (in shares) at Jul. 01, 2022			315
Beginning balance at Jul. 01, 2022	12,323	$ (37)	$ 3	3,733	$ (128)	(579)	9,166	$ 91
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net(loss) income	(975)
Common stock, ending balance (in shares) at Mar. 31, 2023			320
Ending balance at Mar. 31, 2023	$ 11,741		$ 3	3,831		(375)	8,282
Beginning balance (in shares) at Sep. 30, 2022	0
Beginning balance at Sep. 30, 2022	$ 0
Ending balance (in shares) at Dec. 30, 2022	0
Ending balance at Dec. 30, 2022	$ 0
Common stock, beginning balance (in shares) at Sep. 30, 2022			318
Beginning balance at Sep. 30, 2022	12,222		$ 3	3,641		(726)	9,304
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net(loss) income	(451)						(451)
Employee stock plans (in shares)			1
Employee stock plans	43			43
Stock-based compensation	86			86
Foreign currency translation adjustment	117					117
Net unrealized gain (loss) on derivative contracts	228					228
Common stock, ending balance (in shares) at Dec. 30, 2022			319
Ending balance at Dec. 30, 2022	$ 12,245		$ 3	3,770		(381)	8,853
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of Convertible preferred stock, net of issuance costs (in shares)	1
Issuance of convertible preferred stock, net of issuance costs	$ 876
Ending balance (in shares) at Mar. 31, 2023	1
Ending balance at Mar. 31, 2023	$ 876
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net(loss) income	(571)						(571)
Employee stock plans (in shares)			1
Employee stock plans	(13)			(13)
Stock-based compensation	74			74
Actuarial pension gain	(1)					(1)
Foreign currency translation adjustment	(9)					(9)
Net unrealized gain (loss) on derivative contracts	16					16
Common stock, ending balance (in shares) at Mar. 31, 2023			320
Ending balance at Mar. 31, 2023	$ 11,741		$ 3	3,831		(375)	8,282
Beginning balance (in shares) at Jun. 30, 2023	1
Beginning balance at Jun. 30, 2023	$ 876
Ending balance (in shares) at Sep. 29, 2023	1
Ending balance at Sep. 29, 2023	$ 876
Common stock, beginning balance (in shares) at Jun. 30, 2023	322		322
Beginning balance at Jun. 30, 2023	$ 10,964		$ 3	3,936		(548)	7,573
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net(loss) income	(685)						(685)
Employee stock plans (in shares)			2
Employee stock plans	(43)			(43)
Stock-based compensation	77			77
Foreign currency translation adjustment	(38)					(38)
Net unrealized gain (loss) on derivative contracts	(45)					(45)
Common stock, ending balance (in shares) at Sep. 29, 2023			324
Ending balance at Sep. 29, 2023	$ 10,230		$ 3	3,970		(631)	6,888
Beginning balance (in shares) at Jun. 30, 2023	1
Beginning balance at Jun. 30, 2023	$ 876
Ending balance (in shares) at Mar. 29, 2024	1
Ending balance at Mar. 29, 2024	$ 876
Common stock, beginning balance (in shares) at Jun. 30, 2023	322		322
Beginning balance at Jun. 30, 2023	$ 10,964		$ 3	3,936		(548)	7,573
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net(loss) income	$ (837)
Common stock, ending balance (in shares) at Mar. 29, 2024	326		326
Ending balance at Mar. 29, 2024	$ 10,121		$ 3	4,018		(636)	6,736
Beginning balance (in shares) at Sep. 29, 2023	1
Beginning balance at Sep. 29, 2023	$ 876
Ending balance (in shares) at Dec. 29, 2023	1
Ending balance at Dec. 29, 2023	$ 876
Common stock, beginning balance (in shares) at Sep. 29, 2023			324
Beginning balance at Sep. 29, 2023	10,230		$ 3	3,970		(631)	6,888
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net(loss) income	(287)						(287)
Employee stock plans (in shares)			2
Employee stock plans	33			33
Stock-based compensation	72			72
Purchase of capped calls related to the issuance of convertible notes, net of tax	(118)			(118)
Foreign currency translation adjustment	58					58
Net unrealized gain (loss) on derivative contracts	80					80
Common stock, ending balance (in shares) at Dec. 29, 2023			326
Ending balance at Dec. 29, 2023	$ 10,068		$ 3	3,957		(493)	6,601
Ending balance (in shares) at Mar. 29, 2024	1
Ending balance at Mar. 29, 2024	$ 876
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net(loss) income	135						135
Employee stock plans	(16)			(16)
Stock-based compensation	77			77
Foreign currency translation adjustment	(75)					(75)
Net unrealized gain (loss) on derivative contracts	$ (68)					(68)
Common stock, ending balance (in shares) at Mar. 29, 2024	326		326
Ending balance at Mar. 29, 2024	$ 10,121		$ 3	$ 4,018		$ (636)	$ 6,736